163 Development of clinical and patient-reported quality metrics for multiple sclerosis: a UK pilot study report
dc.contributor.author | Giovannoni, G | |
dc.contributor.author | White, S | |
dc.contributor.author | Mistry, N | |
dc.contributor.author | Calhoun, S | |
dc.contributor.author | Young, C | |
dc.contributor.author | Coutts, M | |
dc.contributor.author | Roberts, M | |
dc.contributor.author | Anderson, P | |
dc.contributor.author | Bernstein, R | |
dc.contributor.author | Hobart, J | |
dc.date.accessioned | 2020-07-24T12:42:55Z | |
dc.date.available | 2020-07-24T12:42:55Z | |
dc.date.issued | 2019-12 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/16100 | |
dc.description.abstract |
<jats:sec><jats:title>Background</jats:title><jats:p>Quality standards (QS) for people with multiple sclerosis (PwMS) are suboptimal, ambiguous and restricted to certain patient subgroups and care pathways.</jats:p></jats:sec><jats:sec><jats:title>Aim</jats:title><jats:p>Develop and pilot MS metrics measuring service provision quality to identify areas for improvement.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A multidisciplinary Working Group developed clinician and patient-reported metrics and standardised data collection forms through an iterative process.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Metrics covered: referral; diagnosis; treatment; annual review; general management; education. Pilot (n=76) showed: 31% of PwMS were referred to MS specialist within 4 weeks of suspected/confirmed demyelination; 28% and 56% had uncomplicated MS confirmed and were offered specialist MS nurse appointment, respectively, within 4 weeks of specialist referral; 75% of eligible PwMS were offered disease-modifying therapy within 8 weeks of confirmed MS diagnosis; 85% had comprehensive multidisciplinary team (MDT) annual review; 90% had a defined point of contact within the MS service; 86% of unscheduled contacts by PwMS, MDT or general practitioners were responded to within 3 days; 53% of MS services maintained a single database of PwMS; and 76% of PwMS were offered ongoing education. Data collection continues and updated findings will be reported.</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>MS metrics/data forms are feasible for routine clinical settings, simple to interpret and provide a valuable benchmark for guiding MS service improvements.</jats:p></jats:sec> | |
dc.language.iso | en | |
dc.subject | Health Services | |
dc.subject | Clinical Research | |
dc.subject | Autoimmune Disease | |
dc.subject | Neurosciences | |
dc.subject | Brain Disorders | |
dc.subject | Neurodegenerative | |
dc.subject | Multiple Sclerosis | |
dc.subject | 8.1 Organisation and delivery of services | |
dc.subject | 7.1 Individual care needs | |
dc.subject | Neurological | |
dc.title | 163 Development of clinical and patient-reported quality metrics for multiple sclerosis: a UK pilot study report | |
dc.type | presentation | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000522138000174&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
dc.identifier.doi | 10.1136/jnnp-2019-abn-2.150 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1136/jnnp-2019-abn-2.150 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Other |